Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Pediatric Cancer

Overview of Cell Viability and Cytotoxicity

Hot vs Cold: the differences between tumor types

Cancer Epidemiology

CDK9 and Cancer

Extracellular Vesicles as Floating Cancer Biomarkers

Cancer Prevention: Lowering your Risk

Exploiting Enzymes in Cancer Diagnosis and Therapy

Investigating the Molecular Mechanisms of Cancer

Assay for Monitoring and Treating Malignant Brain Tumors

See more featured articles »

Cancer Pathophysiology

Cancer Prognosis

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

What is Merkel Cell Carcinoma?

Targeted Cancer Therapies

Secondary Brain Cancer

Cancer Symptoms

Metastatic Migration in Cancer may be Influenced by Metabolism

What is the Tumor Microenvironment?

Microfluidic cancer treatment screen combined with flow cytometry

Cancer Research

Using Biomarkers to Detect Cancer

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Living with Cancer Pain

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

What Causes Cancer?

Insights into Oncofertility

Cancer Pain

Hypoxia Markers and Their Importance

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Acidosis and Tumor Progression

Cancer Pain Management

The Biochemistry of Breast Cancer Screening

Why are Cancer Cell Lines Useful?

The Effects of Cancer on Family Life

TARDIS: The Improved Method of Detecting Breast Cancer

Transforming Cancer Care through Genomic Testing

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

What is Cancer of Unknown Primary?

Cancer Classification

Secondary Lung Cancer

Cancer Screening Considerations: Balancing the Benefits and Risks

Cancer Management

Is Cancer a Metabolic Disorder?

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

What is Tumorigenesis?

Cancer History

Insight into Cancer Vaccines

British Pioneers in Cancer Biology

Cancer Glossary

Cutaneous Manifestations of Internal Malignancy

What Role do Biobanks Play in Cancer Research?

Cancer Diagnosis

Effects of Social and Economic Deprivation on Cancer Mortality

What is Cancer?

What is Immunochemotherapy?

The Cancer Cell Surface Proteome as a Therapeutic Target

Caring for a Loved One with Cancer

Myc Mutations and Cancer

Latest Cancer News and Research

New peptide triggers domino effect to suppress bladder cancer

Recently, a research team led by Professors Dahong Zhang and Qi Zhang from the Urology Department and the Institute of Urology at Zhejiang Provincial People's Hospital and the Translational Medicine Center discovered that a bladder tumor-targeting polyarginine peptide, R11, can directly bind to actin, destabilize the G-actin tetramer, and trigger the cascade breakdown of the actin-plectin-vimentin/ITGβ4 axis (referred to as the "cytoskeletal domino effect").

25 May 2026

Senolytic therapy delays early disc degeneration in mouse model

Targeting senescent cells with dasatinib-quercetin preserves disc structure and modulates degeneration-associated pathways in a mouse model.

25 May 2026

Ferroptosis exploits unique cancer metabolic vulnerabilities to bypass traditional apoptotic evasion pathways

A new wave of scientific understanding is placing ferroptosis, a distinct form of iron-dependent cell death, at the forefront of efforts to overcome drug resistance in digestive cancers. These cancers, which include gastric, colorectal, liver, pancreatic, and esophageal malignancies, remain among the most challenging to treat due to their ability to evade standard therapies.

25 May 2026

Small non-coding RNA molecule precisely controls vital gene expression and cellular balance

A rapidly advancing area of biomedical innovation is shining a spotlight on miR-128-3p, a small yet powerful molecule with the potential to reshape how diseases—especially cancer—are detected, monitored, and treated. This microRNA, part of a broader class of non-coding RNAs, plays a critical role in regulating gene activity and maintaining cellular homeostasis.

25 May 2026

Metabolic reprogramming helps tumor cells adapt and evade the human immune system

A newly published review article highlights the critical role of fatty acid metabolism in shaping the tumor microenvironment and influencing cancer progression, offering fresh perspectives for the development of more effective therapies.

25 May 2026

Sting signaling stimulates vital immune defenses to actively suppress aggressive tumor growth

A new review brings attention to the STING pathway as a critical regulator in both colitis and colon cancer, highlighting its complex and often opposing roles in inflammation and tumor development. The findings underscore how this key component of the innate immune system can act as both a driver of disease and a protective mechanism, depending on biological context.

25 May 2026

New review highlights how glutamine metabolism shapes the complex tumor microenvironment

A new review article highlights the expanding importance of glutamine metabolism in shaping the tumor microenvironment, offering fresh perspectives on how metabolic interactions influence cancer progression and therapeutic response

25 May 2026

Researchers link surgical weight loss to reduced female cancer mortality rates

Substantial and sustained weight-loss has been linked to a reduced risk of cancer and cancer-related death, mainly in women. Two new studies now provide clues to why the risk is reduced - and suggest that gender, metabolism and genetics may play a crucial role.

25 May 2026

Scientists reveal why common pancreatic precancer lesions rarely turn deadly

Spatial and single-cell analyses of human donor pancreata showed that PanIN epithelial cells gradually acquire cancer-like molecular features, while their surrounding stromal and immune environment remains closer to normal pancreatic tissue. The findings suggest that delayed or incomplete microenvironmental reprogramming may help explain why most PanIN lesions remain indolent rather than progressing to pancreatic cancer.

24 May 2026

New advances improve prevention and treatment of HPV-related cancers

A new review article is drawing attention to the growing global impact of human papillomavirus (HPV) and the rapid progress in vaccines and therapeutic strategies aimed at reducing the burden of cervical and non-cervical cancers.

24 May 2026

RNA regulator RBM15 linked to immunity, metabolism, and cancer progression

A newly published review article brings attention to the expanding role of RBM15, a critical regulator of RNA m6A methylation, in the development and progression of a wide range of diseases, including cancer, metabolic disorders, and cardiovascular conditions.

24 May 2026

Efferocytosis plays central role in wound healing and tissue repair

A new review shines a spotlight on efferocytosis, a critical biological process responsible for the removal of dead cells, as a central force in promoting efficient wound repair and maintaining tissue balance.

24 May 2026

DNA methylation variability may improve precision cancer treatment strategies

A new review article brings attention to the critical role of DNA methylation heterogeneity in shaping the tumor microenvironment, highlighting its growing importance in understanding cancer progression and advancing more precise treatment strategies.

24 May 2026